BPC-157 vs GHK-Cu
BPC-157 and GHK-Cu both appear in tissue repair and regenerative research contexts, but they address fundamentally different biological problems. BPC-157 is a systemic cytoprotective agent with documented effects across the gastrointestinal tract, tendons, ligaments, and CNS, acting through nitric oxide pathways and growth factor signaling. GHK-Cu is a naturally occurring copper-binding tripeptide that acts locally on fibroblasts and extracellular matrix, influencing collagen synthesis, wound healing, and copper-dependent antioxidant systems. Researchers selecting between them typically differentiate based on the tissue type and repair mechanism under study.
BPC-157
Pentadecapeptide (15 amino acids)
GHK-Cu
Copper-binding tripeptide (Gly-His-Lys plus Cu2+)
At a Glance
Key research profiles for each compound.
BPC-157
Gastric pentadecapeptide studied for cytoprotection and systemic tissue repair
Class
Pentadecapeptide (15 amino acids)
Mechanism
NO pathway, growth factor upregulation, angiogenesis
Half-Life
Under 4 hours in preclinical models
Research Area
Gut, tendon, CNS, vascular repair
- Studied for tendon, ligament, and connective tissue repair in animal models
- Documented effects on gut-brain axis and gastrointestinal cytoprotection
- Investigated for angiogenesis and nitric oxide pathway modulation
- Examined for CNS protective properties in traumatic injury models
GHK-Cu
Copper tripeptide studied for collagen synthesis and extracellular matrix repair
Class
Copper-binding tripeptide (Gly-His-Lys plus Cu2+)
Mechanism
Copper delivery, ECM remodeling, collagen synthesis regulation
Half-Life
Rapidly cleared, endogenous plasma peptide
Research Area
Skin, collagen, wound healing, antioxidant biology
- Investigated for collagen I and III synthesis upregulation in fibroblast models
- Documented copper-dependent antioxidant and free radical scavenging activity
- Studied for wound healing acceleration and ECM remodeling in vitro
- Examined for gene expression modulation across 4,000 or more human genes
Side-by-Side Comparison
Key research parameters compared directly.
| Feature | BPC-157 | GHK-Cu |
|---|---|---|
| Peptide Class | Pentadecapeptide (15 AA) | Copper-binding tripeptide (3 AA) |
| Primary Mechanism | NO pathway, angiogenesis, growth factor signaling | Collagen synthesis, copper ion delivery, ECM remodeling |
| Primary Research Target | Gut, tendon, CNS, vascular | Skin, fibroblasts, extracellular matrix |
| Molecular Weight | ~1,419 Da | ~340 Da (plus Cu2+) |
| Natural Occurrence | Synthetic partial sequence of gastric BPC | Endogenous, found in human plasma |
| Research Depth | 1,000 or more preclinical studies in literature | 4,000 or more genes documented, decades of fibroblast research |
| Systemic Effect | Broad systemic distribution in models | Primarily local and tissue-level action |
| Key Co-Research | TB-500, Thymosin Alpha-1 | Epithalon, TB-500 in ECM contexts |
Research Deep-Dive
BPC-157
BPC-157's systemic cytoprotective profile makes it one of the most researched peptides in preclinical gastroenterology and connective tissue biology. Its partial sequence derived from gastric BPC confers acid stability and sustained activity in the GI environment. Beyond gut research, BPC-157 has been examined in tendon transection models, showing accelerated collagen remodeling and restoration of mechanical properties in treated versus control groups. Its interactions with the dopaminergic and serotonergic systems have also made it a subject of CNS and mood-related preclinical studies. The nitric oxide pathway is considered its primary signaling mechanism, influencing blood flow, tissue oxygenation, and growth factor availability at repair sites.
View BPC-157 →GHK-Cu
GHK-Cu's profile in tissue repair research is focused primarily on the extracellular matrix and fibroblast biology. As an endogenous tripeptide whose plasma levels decline by approximately 50 to 60 percent between ages 20 and 60, GHK-Cu has been studied as a potential modulator of age-related matrix degradation. In fibroblast culture studies, GHK-Cu stimulates collagen Type I and III synthesis, upregulates glycosaminoglycan production, and modulates matrix metalloproteinase activity. Its copper-binding activity also contributes to superoxide dismutase function, giving it a dual role in both structural and oxidative stress research. Unlike BPC-157, GHK-Cu's primary target tissue is the dermis and wound bed rather than the gut or CNS.
View GHK-Cu →Research Context
These two compounds are sometimes studied together when the research question spans multiple tissue types. For example, models examining both gut repair and dermal wound healing simultaneously benefit from including both. BPC-157 covers the systemic and CNS aspects while GHK-Cu addresses the local extracellular matrix. Researchers studying post-surgical tissue repair, age-related collagen decline, or comprehensive wound healing models frequently include both in their compound selection.
Frequently Asked Questions
Research Use Cases
Source Both Compounds
BPC-157 and GHK-Cu are both available from Spartan Peptides at ≥98% HPLC-verified purity. Domestic US supply, same-day dispatch before 2 PM. All products for in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.